High adherence to a Mediterranean diet was significantly associated with sleep duration, sleep quality, and chronotype.

Decreases in exclusive cigarette smoking and increases in exclusive electronic cigarette use were seen among US adults from 2017 to 2023.

Music-based therapeutic interventions may improve depressive symptoms and overall behavioral problems in the short term for people with dementia.

Thirty-one million people, or 12% of the US adult population, borrowed $74 million last year to help pay medical costs for themselves or a family member.

Evidence relating to barriers to and facilitators of clinical preventive service use in people with disabilities is limited.

Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.

Ocular surface disease symptoms in individuals with comorbid atopic dermatitis are more common and severe, and self-rated vision is worse.

Sexual satisfaction is negatively impacted by living with Sjögren disease and is strongly correlated with depressive symptoms.

Five years from the start of the COVID-19 pandemic, numerous academic studies have shown how the novel coronavirus affects ocular health.

The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.

People with disabilities (PwD) are more likely to report negative experiences with the cultural responsiveness of health care providers (HCPs).

From 2011 to 2022, mental health inequities by age, sex, and racial and ethnic group, were large, fluctuated over time, and matched prior research.